Rein Therapeutics Statistics
Total Valuation
RNTX has a market cap or net worth of $43.11 million. The enterprise value is $35.68 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RNTX has 21.99 million shares outstanding. The number of shares has increased by 285.32% in one year.
| Current Share Class | 21.99M |
| Shares Outstanding | 21.99M |
| Shares Change (YoY) | +285.32% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 1.10% |
| Owned by Institutions (%) | 15.19% |
| Float | 18.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39
| Current Ratio | 1.39 |
| Quick Ratio | 1.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.78% and return on invested capital (ROIC) is -23.47%.
| Return on Equity (ROE) | -86.78% |
| Return on Assets (ROA) | -21.14% |
| Return on Invested Capital (ROIC) | -23.47% |
| Return on Capital Employed (ROCE) | -51.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.57M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.30% in the last 52 weeks. The beta is 1.77, so RNTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | -43.30% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 2.44 |
| Relative Strength Index (RSI) | 52.96 |
| Average Volume (20 Days) | 52,214 |
Short Selling Information
The latest short interest is 113,654, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 113,654 |
| Short Previous Month | 72,980 |
| Short % of Shares Out | 0.52% |
| Short % of Float | 0.61% |
| Short Ratio (days to cover) | 1.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.52M |
| Pretax Income | n/a |
| Net Income | -61.27M |
| EBITDA | -26.50M |
| EBIT | -26.52M |
| Earnings Per Share (EPS) | -$2.87 |
Full Income StatementBalance Sheet
The company has $7.43 million in cash and n/a in debt, giving a net cash position of $7.43 million or $0.34 per share.
| Cash & Cash Equivalents | 7.43M |
| Total Debt | n/a |
| Net Cash | 7.43M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 49.88M |
| Book Value Per Share | 0.22 |
| Working Capital | 2.35M |
Full Balance SheetCash Flow
| Operating Cash Flow | -23.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | -23.20M |
| FCF Per Share | -$1.05 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |